Literature DB >> 18804137

Vaccine injection technique and reactogenicity--evidence for practice.

Helen Petousis-Harris1.   

Abstract

There are inconsistencies in recommendations and practice with regards to how best to administer vaccines. This review evaluates the literature on intramuscular vaccine administration technique in primarily paediatric populations and concludes from available evidence which aspects of vaccine administration are associated with reactogenicity. Variables with best evidence to support practice to reduce reactogenicity were: Site of injection--less reactogenicity has been noted when the buttock is used rather than the thigh; tissue (muscle or subcutaneous)--less reactions are noted when vaccine is administered intramuscularly rather than subcutaneously; length of needle--longer needles are associated with less reactogenicity. Angle of injection--a 90 degrees angle is associated with less reactogenicity than a reduced angle. Despite a need for more empirical studies, there appears to be several vaccine administration techniques relating to needle angle, length, site and depth of injection that result in fewer reactions and these could be considered for public health policy, in conjunction with immunogenicity.

Mesh:

Substances:

Year:  2008        PMID: 18804137     DOI: 10.1016/j.vaccine.2008.08.052

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  10 in total

1.  Appropriate Needle Length Determined by Ultrasonic Echography for Intramuscular Injection in Japanese Elderly over 50 Years.

Authors:  Tetsuo Nakayama; Hisakuni Sekino; Hirokazu Aihara; Minoru Kino
Journal:  Healthcare (Basel)       Date:  2022-04-25

2.  Analgesic and adjuvant properties of exercise with vaccinations in healthy young population.

Authors:  Vivian Y Lee; Erika Bohn-Goldbaum; Jacqueline Fong; Ian G Barr; Robert Booy; Kate M Edwards
Journal:  Hum Vaccin Immunother       Date:  2021-01-26       Impact factor: 3.452

3.  Safety, immunogenicity and immediate pain of intramuscular versus subcutaneous administration of a measles-mumps-rubella-varicella vaccine to children aged 11-21 months.

Authors:  Markus Knuf; Fred Zepp; Claudius U Meyer; Pirmin Habermehl; Lothar Maurer; Hanns-Michael Burow; Ulrich Behre; Michel Janssens; Paul Willems; Helmtrud Bisanz; Volker Vetter; Ruprecht Schmidt-Ott
Journal:  Eur J Pediatr       Date:  2010-02-11       Impact factor: 3.860

4.  Needle size for vaccination procedures in children and adolescents.

Authors:  Paul V Beirne; Sarah Hennessy; Sharon L Cadogan; Frances Shiely; Tony Fitzgerald; Fiona MacLeod
Journal:  Cochrane Database Syst Rev       Date:  2018-08-09

5.  Factors associated with reported pain on injection and reactogenicity to an OMV meningococcal B vaccine in children and adolescents.

Authors:  Helen Petousis-Harris; Catherine Jackson; Joanna Stewart; Gregor Coster; Nikki Turner; Felicity Goodyear-Smith; Diana Lennon
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

Review 6.  Vaccination in elite athletes.

Authors:  Barbara C Gärtner; Tim Meyer
Journal:  Sports Med       Date:  2014-10       Impact factor: 11.136

Review 7.  Administering Multiple Injectable Vaccines During a Single Visit-Summary of Findings From the Accelerated Introduction of Inactivated Polio Vaccine Globally.

Authors:  Samantha B Dolan; Manish Patel; Lee M Hampton; Eleanor Burnett; Daniel C Ehlman; Julie Garon; Emily Cloessner; Elizabeth Chmielewski; Terri B Hyde; Carsten Mantel; Aaron S Wallace
Journal:  J Infect Dis       Date:  2017-07-01       Impact factor: 5.226

8.  Recombinant Pseudorabies Virus with TK/gE Gene Deletion and Flt3L Co-Expression Enhances the Innate and Adaptive Immune Response via Activating Dendritic Cells.

Authors:  Lun Yao; Qiao Hu; Siqi Chen; Tong Zhou; Xuexiang Yu; Hailong Ma; Ahmed H Ghonaim; Hao Wu; Qi Sun; Shengxian Fan; Qigai He
Journal:  Viruses       Date:  2021-04-16       Impact factor: 5.048

9.  Immunogenicity, safety, and tolerability of a recombinant hepatitis B vaccine manufactured by a modified process in healthy young Japanese adults.

Authors:  Hiroyuki Kishino; Kenichi Takahashi; Miyuki Sawata; Yoshiyuki Tanaka
Journal:  Hum Vaccin Immunother       Date:  2018-04-12       Impact factor: 3.452

Review 10.  The how's and what's of vaccine reactogenicity.

Authors:  Caroline Hervé; Béatrice Laupèze; Giuseppe Del Giudice; Arnaud M Didierlaurent; Fernanda Tavares Da Silva
Journal:  NPJ Vaccines       Date:  2019-09-24       Impact factor: 7.344

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.